Lecture 32 Flashcards
Causes of arrhythmias (2)
direct damage to heart (chamber enlargement, cardiomyopathy) systemic abnormalities (electrolyte or acid base abnormalities)
clinical signs of arrhythmias(5)
inadequate CO-> exercise intolerance weakness syncopal episodes sudden development of dysrhythmia may lead to decompensation
Diagnosing arrhythmia
ECG is the key to diagnosis
Most common arrhythmias in dogs(3)
supraventricular tachycardia
atrial premature complexes
atrial fibrillation
Most common arrhythmias in cats (2)
SA block
ventricular premature complexes (VPC)
Normal myocyte depolarization relies on
Pacemaker cell depolarization relies on
Na influx-fast
Ca influx-slow
Na channel blockers
- type of drug
- mechanism of action
- which cells will be more affected
- use for treatment of
antinarrhythmics drug
bind to VO Na channels and inhibit them (pacemaker cells are not reliant on VO Na channels)
Use dependent- more active cells will be more affected
ventricular dysrhythmias
Beta blockers
- type of drug
- mechanism of action
- what do they control
- used to treat
antiarrhythmic drug
inhibit sympathetic stimulation to heart- will slow SA rate and AV conduction
control dysrhythmias driven by excessive sympathetic tone
used to treat atrial tachycardias and fear related behaviors
K channel blockers
- type of drug
- mechanism of action
- often used?
antiarrhythmia drug
block outward K+ channels(in charge of repolarizing cell)
not often used
Ca Channel blockers
- Type of drug-
- mechanism of action
- Which cells are more affected
- used to treat
antiarrhythmia drug
block L type Ca channels (heart and VSM)->dec HR and AV conduction, dec force of contraction, and VSM relaxation
use dependence- more active cells will be more dependent
atrial tachycardia
Digoxin type of drug -Mechanism of action -used to treat -side effect
used as an antiarrhythmic drug
vagal effects on pacemaker tissues- slowed AV conduction and SA rate->dec HR
dec sympathetic drive
shortened refractory period in atria and ventricles
used to treat atrial fibrillation
-BUT can cause ventricular arrhythmia because effect on NA/K ATPase
Atrial fibrillation and supraventricular tachycardia are generally associated with (2)
generally associated with mitral valve failure in dogs and hypertrophic cardiomyopathy in cats
Aim of therapy in atrial fibrillation and supraventricular tachycardia is to (2)
examples of drug types to be used for each
- Inc AV node refractoriness(lengthen refractory period) (digoxin, Beta blocker, Ca channel blocker)
- inc atrial refractoriness(lengthen refractory period) (na channel blocker for atrial fib in horses)
Ventricular tachycardia is generally associated with (3)
associated with severe cardiac or systemic disease, refractory CHF, DCM
Aim of therapy in ventricular tachycardia is to (2)
example of type of drug to be used
treat pre existing disease
dec automaticity and conduction velocity
inc ventricular muscle refractory period (Na channel blockers are drug of choice)